RetractedArticleLeukemia2023

MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia.

Laura Mazzera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.